NCT07688278

Brief Summary

This study will evaluate whether HbA1c screening can be performed in dental care to detect elevated blood glucose in patients with advanced periodontitis and support referral to primary care. Periodontitis is a common chronic inflammatory disease affecting the supporting tissues of the teeth. Advanced periodontitis is associated with prediabetes, type 2 diabetes and cardiovascular disease. The relationship between periodontitis and diabetes is bidirectional: diabetes increases the risk and severity of periodontitis, while periodontal inflammation may contribute to impaired glucose regulation. Patients with advanced periodontitis may therefore represent a group at increased risk of undetected elevated blood glucose. Many of these patients visit dental care regularly but may not otherwise be reached by structured medical prevention. This is a cross-sectional observational feasibility study conducted in public dental clinics in Skåne, Sweden, in collaboration with primary care. Adult patients aged 18 years or older with advanced periodontitis, defined as periodontitis stage 3-4 or grade B/C, will be invited to participate during a routine dental visit. Patients with previously diagnosed diabetes will not be included. After informed consent, participants will complete or update a health declaration and undergo capillary HbA1c testing at the dental clinic using a validated point-of-care instrument. Participants will receive their test result. Those with HbA1c ≥42 mmol/mol will receive standardized information and be referred to their listed primary care centre for further diagnostic assessment and preventive follow-up according to routine clinical practice. The study will assess how feasible this pathway is in routine dental care. Outcomes include participation rate, successful HbA1c testing, time required for study procedures, prevalence of elevated HbA1c, proportion referred to primary care, completed primary care follow-up within six months, dropout and costs. Follow-up data will be collected from medical records and regional registers. The study may provide a practical model for collaboration between dental care and primary care, with the long-term aim of improving early detection of prediabetes and diabetes and strengthening preventive care for patients with advanced periodontitis.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
600

participants targeted

Target at P75+ for not_applicable

Timeline
17mo left

Started Jul 2026

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress7%
Jul 2026Dec 2027

First Submitted

Initial submission to the registry

May 29, 2026

Completed
1 month until next milestone

Study Start

First participant enrolled

July 1, 2026

Completed
6 days until next milestone

First Posted

Study publicly available on registry

July 7, 2026

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 30, 2027

Expected
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2027

Last Updated

July 7, 2026

Status Verified

May 1, 2026

Enrollment Period

1.1 years

First QC Date

May 29, 2026

Last Update Submit

June 30, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • Participation rate

    Number of participants included out of those who meet the inclusion criteria. Reasons for non-participation will be recorded in free text.

    6 months

Secondary Outcomes (5)

  • Proportion of participants with HbA1c 42 mmol/mol or higher.

    6 months

  • Proportion of patients undergoing blood pressure examination at follow-up in primary care

    6 months

  • Proportion of patients undergoing blood lipid laboratory samples

    6 months

  • Diagnosis at follow-up

    6 months

  • Proportion of patients receiving lifestyle advice at follow-up

    6 months

Study Arms (1)

HbA1c Screening in Dental Care

EXPERIMENTAL

Adult patients with advanced periodontitis undergo point-of-care HbA1c screening during a routine dental care visit. Patients with HbA1c ≥42 mmol/mol receive standardized information and are referred to primary care for further assessment and preventive follow-up.

Diagnostic Test: Point-of-care HbA1c screeningOther: Conditional standardized primary care referral

Interventions

All participants undergo capillary HbA1c testing at the dental clinic using a validated point-of-care instrument. Test results are provided to the participant during the visit.

HbA1c Screening in Dental Care

Participants with HbA1c ≥42 mmol/mol receive standardized information about the elevated test result and are referred to their listed primary care centre for further diagnostic assessment and preventive follow-up according to routine clinical practice.

HbA1c Screening in Dental Care

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age 18 years or older.
  • Advanced periodontitis, defined as stage 3-4 periodontitis or grade B/C periodontitis according to clinical and radiographic assessment during routine dental care.
  • Ability to understand study information and provide informed consent.

You may not qualify if:

  • Previously diagnosed diabetes mellitus.
  • Inability to provide informed consent, for example due to severe mental disorder or markedly impaired health status as judged by the clinical staff.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Folktandvården Skåne AB

Skåne, Sweden

RECRUITING

MeSH Terms

Conditions

Chronic PeriodontitisPrediabetic StateDiabetes Mellitus, Type 2

Condition Hierarchy (Ancestors)

PeriodontitisPeriodontal DiseasesMouth DiseasesStomatognathic DiseasesChronic DiseaseDisease AttributesPathologic ProcessesPathological Conditions, Signs and SymptomsDiabetes MellitusGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System Diseases

Central Study Contacts

Peter Nymberg

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
PREVENTION
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 29, 2026

First Posted

July 7, 2026

Study Start

July 1, 2026

Primary Completion (Estimated)

July 30, 2027

Study Completion (Estimated)

December 31, 2027

Last Updated

July 7, 2026

Record last verified: 2026-05

Data Sharing

IPD Sharing
Will not share

Locations